93 related articles for article (PubMed ID: 22101237)
1. Identification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes.
Kim SM; Park JS; Norwitz ER; Lee SM; Kim BJ; Park CW; Jun JK; Kim CW; Syn HC
Reprod Sci; 2012 Feb; 19(2):202-9. PubMed ID: 22101237
[TBL] [Abstract][Full Text] [Related]
2. Proteomic biomarkers in second trimester amniotic fluid that identify women who are destined to develop preeclampsia.
Oh KJ; Park JS; Norwitz ER; Kim SM; Kim BJ; Park CW; Jun JK; Syn HC
Reprod Sci; 2012 Jul; 19(7):694-703. PubMed ID: 22534327
[TBL] [Abstract][Full Text] [Related]
3. Predicting gestational diabetes: choosing the optimal early serum marker.
Smirnakis KV; Plati A; Wolf M; Thadhani R; Ecker JL
Am J Obstet Gynecol; 2007 Apr; 196(4):410.e1-6; discussion 410.e6-7. PubMed ID: 17403439
[TBL] [Abstract][Full Text] [Related]
4. First trimester maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein A in pregnancies complicated by diabetes mellitus.
Savvidou MD; Syngelaki A; Muhaisen M; Emelyanenko E; Nicolaides KH
BJOG; 2012 Mar; 119(4):410-6. PubMed ID: 22324916
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of MCP-1 are increased in women with gestational diabetes.
Klein K; Satler M; Elhenicky M; Brix J; Krzyzanowska K; Schernthaner G; Husslein PW; Schernthaner GH
Prenat Diagn; 2008 Sep; 28(9):845-51. PubMed ID: 18702087
[TBL] [Abstract][Full Text] [Related]
6. Identification of proteomic biomarkers of preeclampsia in amniotic fluid using SELDI-TOF mass spectrometry.
Park JS; Oh KJ; Norwitz ER; Han JS; Choi HJ; Seong HS; Kang YD; Park CW; Kim BJ; Jun JK; Syn HC
Reprod Sci; 2008 May; 15(5):457-68. PubMed ID: 18579854
[TBL] [Abstract][Full Text] [Related]
7. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus.
Tsai PJ; Yu CH; Hsu SP; Lee YH; Huang IT; Ho SC; Chu CH
Nutrition; 2005; 21(11-12):1095-9. PubMed ID: 16308131
[TBL] [Abstract][Full Text] [Related]
8. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester.
Leipold H; Worda C; Gruber CJ; Prikoszovich T; Wagner O; Kautzky-Willer A
Eur J Clin Invest; 2005 Dec; 35(12):752-7. PubMed ID: 16313251
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus.
Yilmaz Ö; Küçük M; Kebapçilar L; Altindag T; Yüksel A; Yuvanç HO; Dal T; Savran Y
Gynecol Endocrinol; 2012 Jan; 28(1):76-9. PubMed ID: 21848392
[TBL] [Abstract][Full Text] [Related]
10. Identification of serum protein biomarkers in biliary atresia by mass spectrometry and enzyme-linked immunosorbent assay.
Song Z; Dong R; Fan Y; Zheng S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):370-5. PubMed ID: 22569524
[TBL] [Abstract][Full Text] [Related]
11. Screening for biomarkers predictive of gestational diabetes mellitus.
Georgiou HM; Lappas M; Georgiou GM; Marita A; Bryant VJ; Hiscock R; Permezel M; Khalil Z; Rice GE
Acta Diabetol; 2008 Sep; 45(3):157-65. PubMed ID: 18496643
[TBL] [Abstract][Full Text] [Related]
12. Increased serum retinol-binding protein 4 concentrations in women with gestational diabetes mellitus.
Chan TF; Chen HS; Chen YC; Lee CH; Chou FH; Chen IJ; Chen SY; Jong SB; Tsai EM
Reprod Sci; 2007 Feb; 14(2):169-74. PubMed ID: 17636228
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of gestational diabetes mellitus: identification of risk factors.
Spong CY; Guillermo L; Kuboshige J; Cabalum T
Am J Perinatol; 1998 Jan; 15(1):29-33. PubMed ID: 9475684
[TBL] [Abstract][Full Text] [Related]
14. Gestational diabetes and maternal third-trimester blood count.
Lao TT; Ho LF
J Reprod Med; 2002 Apr; 47(4):309-12. PubMed ID: 12012883
[TBL] [Abstract][Full Text] [Related]
15. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks.
Nanda S; Savvidou M; Syngelaki A; Akolekar R; Nicolaides KH
Prenat Diagn; 2011 Feb; 31(2):135-41. PubMed ID: 21268030
[TBL] [Abstract][Full Text] [Related]
16. First-trimester nuchal translucency screening in pregnant women who subsequently developed gestational diabetes.
Leipold H; Worda C; Ozbal A; Husslein P; Krampl E
J Soc Gynecol Investig; 2005 Oct; 12(7):529-32. PubMed ID: 16046155
[TBL] [Abstract][Full Text] [Related]
17. Decreased maternal and placental concentrations of follistatin-like 3 in gestational diabetes.
Hu D; Tian T; Guo J; Wang H; Chen D; Dong M
Clin Chim Acta; 2012 Mar; 413(5-6):533-6. PubMed ID: 22122995
[TBL] [Abstract][Full Text] [Related]
18. Early second-trimester plasma protein profiling using multiplexed isobaric tandem mass tag (TMT) labeling predicts gestational diabetes mellitus.
Zhao C; Wang F; Wang P; Ding H; Huang X; Shi Z
Acta Diabetol; 2015 Dec; 52(6):1103-12. PubMed ID: 26259496
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate biomarkers for the prediction of gestational diabetes mellitus in the early stages of pregnancy using iTRAQ quantitative proteomics.
Zhao D; Shen L; Wei Y; Xie J; Chen S; Liang Y; Chen Y; Wu H
Proteomics Clin Appl; 2017 Jul; 11(7-8):. PubMed ID: 28220636
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcomes in pre-gestational and gestational diabetic women in comparison to non-diabetic women--A prospective study in Asian Indian mothers (CURES-35).
Shefali AK; Kavitha M; Deepa R; Mohan V
J Assoc Physicians India; 2006 Aug; 54():613-8. PubMed ID: 16941791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
